Schizophrenia affects millions of people around the world, which is why any prospective treatment that advances garners close attention. Minerva Neurosciences jumped into the spotlight this morning when an experimental schizophrenia drug it’s developing showed some promise in a mid-stage trial,... Read more »
Every June, Xconomy holds a big Boston event looking at the region’s innovation future. This year is no different, but some big changes are in the air for the Boston tech and life sciences communities—and we retooled our event to explore... Read more »
Usually when a biotech company makes a large fundraising announcement, the cash is committed to taking a specific drug through clinical trials. Arrivo BioVentures has secured $49 million in capital to first find the drugs to develop.
The approach is similar... Read more »
Computers can beat humans at games like chess and Go. They are obviously faster than us at calculations and numerical analysis. But they can’t read people’s emotions as well as we can, or do much of anything useful with that information.... Read more »
Deborah Dunsire, the former head of Millennium Pharmaceuticals and a well-known Boston biotech veteran, is no longer the CEO of Forum Pharmaceuticals, Xconomy has learned.
Dunsire’s last day at Waltham, MA-based Forum was on Friday. She told Xconomy she’s formed a... Read more »
Wes Schroll, the founder and CEO of Fetch Rewards, says that in early 2015, his startup received a call from a man who worked at Oscar Mayer, the meat producer known for its hot dogs, bologna, and Wienermobile.
Schroll says the... Read more »
San Antonio — There are obvious physical difficulties that people with spinal-cord injuries face. One that may not be top of mind, but can be both physically and emotionally taxing, is the inability to control their bladders, says Pratap Khanwilkar of... Read more »
Racecar driver Simon Pagenaud started the Angie’s List Grand Prix of Indianapolis from the pole and led 57 of its 82 laps on his way to Victory Circle earlier this month. And Verizon Wireless subscribers across the world were invited along... Read more »
Spero Therapeutics continues to accumulate assets through acquisitions. This morning, the Cambridge, MA-based startup announced a deal to grab rights to a group of experimental antibiotic compounds from Vertex Pharmaceuticals (NASDAQ:VRTX), among them a drug called VXc-486/VXc-100. Spero didn’t... Read more »
Dallas—EquipmentShare, an online marketplace for construction equipment, has raised $5.5 million in a Series A funding round.
Boston’s Romulus Capital is providing the funding. EquipmentShare essentially works to bring the construction site into the digital age. The company’s website works... Read more »